Hospital
Anaheim Global Medical Center, INC
Anaheim Global Medical Center, INC was paid $4.29M by Medicaid between Jan 2018 and Dec 2024, across 150 billing codes. Its largest line is 0450, Emergency room services — 11% of everything it billed.
33Billing provider infoANAHEIM GLOBAL MEDICAL CENTER, INC
ANAHEIM, CA 92805
ANAHEIM, CA 92805
33aNPI1790778488assigned 08/26/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.29M
24GClaims283,973
24DCodes billed150
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#234 of 410
Median peer was paid$6.90M
This provider vs. median0.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official THOMAS, WILLIAM controls 14+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 41,163 | $350K | |
| 2019 | 44,029 | $857K | |
| 2020 | 35,332 | $430K | |
| 2021 | 41,657 | $460K | |
| 2022 | 45,119 | $568K | |
| 2023 | 43,830 | $753K | |
| 2024incomplete | 32,843 | $877K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 11% | 30,155 | 26,795 | $492K |
| A0429 | Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) | 9.5% | 5,168 | 3,916 | $410K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 8.2% | 7,972 | 6,338 | $352K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.3% | 4,882 | 4,345 | $227K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.9% | 1,040 | 957 | $209K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 4.1% | 31,211 | 3,671 | $177K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.2% | 2,635 | 2,491 | $139K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 2.7% | 1,744 | 1,711 | $118K |
| Z7502 | 2.7% | 3,110 | 3,034 | $116K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.7% | 18,235 | 16,104 | $115K |
| 80053 | Comprehensive metabolic panel | 2.4% | 13,795 | 12,351 | $103K |
| 76801 | 2.3% | 1,982 | 1,772 | $98K |
138 more codes
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.3% | 3,957 | $98K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.2% | 5,138 | $94K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.9% | 5,399 | $82K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 1.9% | 2,046 | $81K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.7% | 2,809 | $74K |
| 59025 | Fetal non-stress test | 1.7% | 4,510 | $74K |
| 99199 | Unlisted special service, procedure or report | 1.6% | 1,246 | $71K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1.6% | 1,313 | $68K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1.4% | 1,194 | $59K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.2% | 3,098 | $52K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.1% | 1,414 | $49K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.1% | 510 | $48K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.1% | 1,197 | $47K |
| Z9725 | 1.0% | 1,285 | $45K | |
| 76830 | Ultrasound, transvaginal | 1.0% | 792 | $44K |
| 76813 | <1% | 944 | $39K | |
| J3490 | Unclassified drugs | <1% | 8,738 | $37K |
| 71045 | Radiologic examination, chest; single view | <1% | 4,197 | $36K |
| 84484 | <1% | 4,594 | $33K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 973 | $32K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 4,432 | $29K |
| 83880 | <1% | 1,300 | $26K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,804 | $26K |
| 83690 | <1% | 4,755 | $24K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,171 | $22K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,618 | $22K |
| 87631 | <1% | 520 | $21K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,832 | $21K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 501 | $21K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 485 | $19K |
| 81025 | <1% | 6,339 | $17K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,454 | $16K |
| 87650 | <1% | 1,345 | $16K | |
| 81001 | <1% | 7,650 | $16K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 931 | $15K |
| 99283 | Emergency room visit (moderate) | <1% | 1,493 | $14K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 810 | $14K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,330 | $13K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 184 | $12K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 220 | $11K |
| 0270 | <1% | 14,283 | $10K | |
| 83605 | <1% | 1,306 | $9K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,336 | $9K |
| 85730 | <1% | 2,355 | $8K | |
| 93458 | <1% | 13 | $8K | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,188 | $8K |
| 85610 | <1% | 2,846 | $7K | |
| 82948 | <1% | 2,620 | $7K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 545 | $7K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,042 | $6K |
| 87070 | <1% | 1,302 | $6K | |
| 99284 | Emergency room visit (serious) | <1% | 467 | $6K |
| 87186 | <1% | 868 | $6K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,076 | $5K |
| 84702 | <1% | 926 | $5K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 105 | $5K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 67 | $5K |
| 0360 | <1% | 1,347 | $5K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 892 | $5K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 770 | $5K |
| 80305 | <1% | 481 | $4K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 922 | $4K |
| 90715 | <1% | 139 | $4K | |
| 99285 | Emergency room visit (most serious) | <1% | 57 | $4K |
| 82150 | <1% | 871 | $3K | |
| 0710 | <1% | 1,608 | $3K | |
| 88342 | <1% | 245 | $3K | |
| 83735 | <1% | 571 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 448 | $3K |
| 84703 | <1% | 1,212 | $2K | |
| Z7610 | <1% | 257 | $2K | |
| 86901 | <1% | 1,126 | $2K | |
| 86900 | <1% | 1,124 | $2K | |
| 88313 | <1% | 230 | $2K | |
| 0250 | <1% | 1,683 | $2K | |
| 87040 | <1% | 239 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 265 | $1K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 12 | $1K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 62 | $1K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 210 | $1K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 272 | $1K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 141 | $1K |
| 73564 | <1% | 45 | $862.40 | |
| 0300 | <1% | 1,325 | $824.73 | |
| 73130 | <1% | 45 | $797.02 | |
| 87077 | <1% | 107 | $776.43 | |
| 82553 | <1% | 145 | $720.37 | |
| 73610 | <1% | 50 | $697.02 | |
| 73630 | <1% | 44 | $658.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 64 | $631.33 |
| 85027 | <1% | 122 | $616.15 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 120 | $589.17 |
| 82550 | <1% | 141 | $587.84 | |
| 86850 | <1% | 251 | $484.36 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 135 | $476.82 |
| 88312 | <1% | 47 | $422.12 | |
| 76857 | <1% | 14 | $383.89 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 81 | $347.20 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 71 | $317.93 |
| 74021 | <1% | 14 | $311.25 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 47 | $294.67 |
| 82009 | <1% | 78 | $272.75 | |
| J3486 | Injection, ziprasidone mesylate, 10 mg | <1% | 60 | $269.00 |
| 0762 | <1% | 452 | $233.88 | |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 28 | $218.37 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 19 | $216.57 |
| A4217 | Sterile water/saline, 500 ml | <1% | 28 | $207.48 |
| 0370 | <1% | 317 | $203.80 | |
| 87081 | <1% | 30 | $179.32 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,087 | $177.96 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 13 | $173.54 |
| 84550 | <1% | 48 | $137.67 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 14 | $123.52 |
| 84460 | <1% | 32 | $116.91 | |
| 87420 | <1% | 60 | $114.26 | |
| 84450 | <1% | 32 | $112.65 | |
| 82565 | <1% | 32 | $110.07 | |
| 84520 | <1% | 32 | $80.43 | |
| 0100U | <1% | 130 | $76.30 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 12 | $75.75 |
| 87088 | <1% | 12 | $46.89 | |
| 81003 | <1% | 25 | $44.42 | |
| 87147 | <1% | 12 | $36.54 | |
| 99001 | <1% | 335 | $8.85 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 30 | $3.04 |
| 80320 | 0% | 101 | $0.00 | |
| 0324 | 0% | 53 | $0.00 | |
| 0310 | 0% | 24 | $0.00 | |
| 0254 | 0% | 32 | $0.00 | |
| 0636 | 0% | 175 | $0.00 | |
| 76818 | 0% | 117 | $0.00 | |
| 0260 | 0% | 95 | $0.00 | |
| 0760 | 0% | 236 | $0.00 | |
| 0160 | 0% | 60 | $0.00 | |
| 0402 | 0% | 143 | $0.00 | |
| 0320 | 0% | 39 | $0.00 | |
| 0272 | 0% | 106 | $0.00 | |
| 0481 | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTHOMAS, WILLIAM (OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Trusted Nurse Staffing | Buffalo, NY | $85.30M |
| KPC Global Medical Centers, INC. | Hemet, CA | $29.34M |
| Victor Valley Hospital Acquisition, INC. | Victorville, CA | $26.63M |
| KPC Global Medical Centers, INC. | Sun City, CA | $8.91M |
| Orange County Global Medical Center, INC | Santa Ana, CA | $8.60M |
| Pediatric and Adolescent Dentistry, LLC | Birmingham, AL | $5.29M |
| South Coast Global Medical Center, INC | Santa Ana, CA | $4.53M |
| South Coast Global Medical Center, INC | Santa Ana, CA | $3.98M |
| Chapman Global Medical Center, INC | Orange, CA | $2.92M |
| Chapman Global Medical Center, INC | Orange, CA | $761K |
| New Creek Family Medicine PLLC | Keyser, WV | $580K |
| Delaware Neurology Associates,pa | Lewes, DE | $75K |
| Anaheim Global Medical Center, INC | Anaheim, CA | $20K |
| Orange County Global Medical Center, INC | Santa Ana, CA | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.